Compounds > 4-aminopyridine

4-aminopyridine and fluorodeoxyglucose f18

4-aminopyridine has been researched along with fluorodeoxyglucose f18 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartenstein, P; Bense, S; Best, C; Buchholz, HG; Dieterich, M; Schreckenberger, M; Wiener, V1
Brandt, T; Jahn, K; Kremmyda, O; la Fougère, C; Strupp, M; Zwergal, A1
Bartenstein, P; Beck, R; Böning, G; Brandt, T; Dieterich, M; Günther, L; Jahn, K; la Fougère, C; Potschka, H; Strupp, M; Xiong, G; Zwergal, A1
de la Rosa, RF; Delgado, M; García-García, L; Pozo, MA; Shiha, AA1

Other Studies

4 other study(ies) available for 4-aminopyridine and fluorodeoxyglucose f18

ArticleYear
18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus.
    Neuroreport, 2006, Apr-24, Volume: 17, Issue:6

    Topics: 4-Aminopyridine; Aged; Cerebellum; Eye Movements; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Nystagmus, Pathologic; Positron-Emission Tomography; Potassium Channel Blockers

2006
4-Aminopyridine suppresses positional nystagmus caused by cerebellar vermis lesion.
    Journal of neurology, 2013, Volume: 260, Issue:1

    Topics: 4-Aminopyridine; Cerebellar Diseases; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Nystagmus, Pathologic; Positron-Emission Tomography; Potassium Channel Blockers

2013
The mixed blessing of treating symptoms in acute vestibular failure--evidence from a 4-aminopyridine experiment.
    Experimental neurology, 2014, Volume: 261

    Topics: 4-Aminopyridine; Animals; Brain; Disease Models, Animal; Drug Administration Schedule; Fluorodeoxyglucose F18; Male; Nystagmus, Pathologic; Positron-Emission Tomography; Postural Balance; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Sensation Disorders; Severity of Illness Index; Statistics as Topic; Time Factors; Vestibular Diseases; Vestibule, Labyrinth

2014
Subacute Fluoxetine Reduces Signs of Hippocampal Damage Induced by a Single Convulsant Dose of 4-Aminopyridine in Rats.
    CNS & neurological disorders drug targets, 2017, Volume: 16, Issue:6

    Topics: 4-Aminopyridine; Animals; Brain Injuries; Caspase 9; Cell Death; Convulsants; Disease Models, Animal; Fluoresceins; Fluorodeoxyglucose F18; Fluoxetine; Glial Fibrillary Acidic Protein; Gliosis; Hippocampus; Male; Phosphopyruvate Hydratase; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Reaction Time; Selective Serotonin Reuptake Inhibitors

2017